NCT05402917

Brief Summary

In patients who undergoing lobectomy with thoracotomy incision, the effectiveness of erector spina plane block in post-operative analgesia management is at least as much as thoracic epidural anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 25, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 2, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
Last Updated

May 7, 2024

Status Verified

May 1, 2024

Enrollment Period

10 months

First QC Date

May 25, 2022

Last Update Submit

May 4, 2024

Conditions

Keywords

ESPBTEATHORACOTOMY

Outcome Measures

Primary Outcomes (2)

  • Visual Analogue Scale (VAS) Change

    The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be').

    The first 24 hours postoperatively is the end time for primary outcome measurement.Visual Analogue Scale (VAS) change values for both groups will be recorded at 0, 2, 4, 8, 16 and 24 hours after their admittance to the intensive care unit.

  • Wong-Baker Face Pain Scale (FS) Change

    The scale shows a series of faces ranging from a happy face at 0, or "no hurt", to a crying face at 10, which represents "hurts like the worst pain imaginable.

    The first 24 hours postoperatively is the end time for primary outcome measurement.Wong-Baker Face Pain Scale(FS) values change for both groups will be recorded at 0, 2, 4, 8, 16 and 24 hours after their admittance to the intensive care unit.

Secondary Outcomes (5)

  • Hemodynamic Values Change

    The first 24 hours postoperatively is the end time for secondary outcome measurement. Hemodynamic values change for both groups will be recorded at 0, 2, 4, 8, 16 and 24 hours after their admittance to the intensive care unit.

  • Pulse Oximetry(SpO2) Change

    The first 24 hours postoperatively is the end time for secondary outcome measurement. Pulse Oximetry(SpO2) change values for both groups will be recorded at 0, 2, 4, 8, 16 and 24 hours after their admittance to the intensive care unit.

  • Postoperative Nausea and Vomiting(PONV) Change

    The first 24 hours postoperatively is the end time for secondary outcome measurement. Postoperative nausea or vomiting change for both groups will be recorded at 0, 2, 4, 8, 16 and 24 hours after their admittance to the intensive care unit.

  • Nonsteroidal Anti-inflammatory Drug Usage Need Change

    The first 24 hours postoperatively is the end time for secondary outcome measurement. Nonsteroidal anti-inflammatory drug usage need change for both groups will be recorded at 0, 2, 4, 8, 16 and 24 hours after their admittance to the intensive care unit.

  • Opioid Drug Usage Need Change

    The first 24 hours postoperatively is the end time for secondary outcome measurement. Opioid drug usage need change for both groups will be recorded at 0, 2, 4, 8, 16 and 24 hours after their admittance to the intensive care unit.

Study Arms (2)

Thoracic Epidural Analgesia (TEA)

For patients undergoing TEA is done under general anesthesia after surgery procedure.Once the catheter is secured, a bolus dose of 15 ml of 0.25% bupivacaine will be administered as an epidural injection through the catheter, followed by a continuous infusion of 0.125% bupivacaine at a rate of 0.1 mL/kg/h for the postoperative 24-hour period.

Erector Spina Plan Block (ESPB)

For patients undergoing ESPB is done under general anesthesia after surgery procedure.A bolus dose of 15 mL of 0.25% bupivacaine will be administered from the inserted catheter. Subsequently, 0.125% bupivacaine will be given continuously at a rate of 0.1 mL/kg/h for up to 24 hours post-operatively.

Procedure: Erector Spinae Plane Block

Interventions

Interfascial plane (area) blocks are blocks in which the local anesthetic agent is injected into the potential area between the two fasciae. The ESPB we used in our study is a member of interfascial plane blocks. The erector is applied between the spinal muscle and the transverse process, spreading the drug from the injection site to both cranial and caudal. Unlike other defined interfascial plane blocks, ESPB can show paraspinal block characteristics since the injection site is above the transverse process.

Erector Spina Plan Block (ESPB)

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients undergoing lobectomy with thoracotomy incision

You may qualify if:

  • Lobectomy planned with thoracotomy incision;
  • Adult aged 18-75;
  • American Society of Anesthesiology(ASA) score1-3.

You may not qualify if:

  • Obesity (BMI greater than 35 kg/m2)
  • Local infection at the injection site,
  • Presence of known coagulopathy
  • Bone or brain metastasis
  • Having impaired liver or kidney function
  • Patients who cannot evaluate VAS as cognitive function
  • Patients who cannot use the Patient-Controlled Analgesia (PCA) pump as a -cognitive function
  • History of chronic pain medication use
  • Allergy to the drugs to be used in the study
  • Withdrawing consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr.Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Asistant Doctor

Study Record Dates

First Submitted

May 25, 2022

First Posted

June 2, 2022

Study Start

February 1, 2022

Primary Completion

December 1, 2022

Study Completion

January 1, 2023

Last Updated

May 7, 2024

Record last verified: 2024-05

Locations